Prosecution Insights
Last updated: October 08, 2026

Yungjin Pharm Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Yungjin Pharm Co. Ltd. maintains a concentrated patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action, which constitutes its entire active prosecution workload. This matter is assigned to 1 distinct examiner, AL-AWADI, DANAH J. As the busiest examiner for the portfolio, AL-AWADI, DANAH J is handling 1 pending case. This singular focus suggests that the company's immediate goals in the Biotechnology & Pharmaceuticals sector are being managed through a unified official channel.

The portfolio is limited to 1 distinct art unit, which suggests a very specific technical focus. This narrow distribution means that the company's prosecution strategy is not spread across different examination groups. For a practitioner, the existence of 1 pending office action provides an opportunity for a dedicated and precise response to the examiner's requirements. Since there is only 1 distinct examiner involved, the company can focus on addressing the specific preferences of AL-AWADI, DANAH J. The concentration in 1 distinct art unit ensures that the technical arguments are evaluated by a single specialized group, providing a consistent environment for the company's patent development.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AL-AWADI, DANAH J 1 54.3% +13.5%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17919855 ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAME AL-AWADI, DANAH J —

Top Art Units

Art UnitApps
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17919855 ENTERIC-COATED PREPARATION COMPRISING PIRFENIDONE HAVING IMPROVED SAFETY AND STABILITY, AND METHOD FOR PREPARING SAME AL-AWADI, DANAH J 1615 §103 Final Rejection — Pending Oct 19, 2022

Managing Yungjin Pharm Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Yungjin Pharm Co. Ltd. have?

Yungjin Pharm Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Yungjin Pharm Co. Ltd. applications?

Danah J Al-Awadi has the most, with 1 of Yungjin Pharm Co. Ltd.'s pending office actions.

What technology area are Yungjin Pharm Co. Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month